CPB
45
-4
MO
65
3
FRT
51
-7
CFG
53
-6
PPL
52
-2
HAS
66
-3
VTR
70
-2
FMC
33
2
ZTS
25
-6
AMAT
66
-2
COF
47
-3
STT
40
-4
TGT
50
-2
IR
50
-5
PYPL
20
-2
COST
51
-2
VRTX
56
-2
MCK
77
-3
MDLZ
46
-7
ZION
57
-2
CPB
45
-4
MO
65
3
FRT
51
-7
CFG
53
-6
PPL
52
-2
HAS
66
-3
VTR
70
-2
FMC
33
2
ZTS
25
-6
AMAT
66
-2
COF
47
-3
STT
40
-4
TGT
50
-2
IR
50
-5
PYPL
20
-2
COST
51
-2
VRTX
56
-2
MCK
77
-3
MDLZ
46
-7
ZION
57
-2
Financhill
Back

Biogen, Inc. Stock Price Chart

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
52

BIIB
Biogen, Inc.

Last Price:
$191.97
Seasonality Move:
-3.75%

7 Day Trial

ALL ACCESS PASS

$ 7
  • The current trend is moderately bullish and BIIB is experiencing slight selling pressure.

Biogen, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 193.48 Sell
20-day SMA: 184.96 Buy
50-day SMA: 179.51 Buy
200-day SMA: 150.33 Buy
8-day EMA: 192.51 Sell
20-day EMA: 187.33 Buy
50-day EMA: 179.86 Buy
200-day EMA: 161.84 Buy

Biogen, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.14 Buy
Relative Strength Index (14 RSI): 58.18 Buy
Chaikin Money Flow: -474606 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (170.73 - 192.43) Buy
Bollinger Bands (100): (153.14 - 184.28) Buy

Biogen, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Biogen, Inc. Stock

Is Biogen, Inc. Stock a Buy?

  • Biogen, Inc. share price is 192.08 while BIIB 8-day simple moving average is 193.48, which is a Sell signal.
  • The stock price of BIIB is 192.08 while Biogen, Inc. 20-day SMA is 184.96, which makes it a Buy.
  • Biogen, Inc. 50-day simple moving average is 179.51 while BIIB share price is 192.08, making it a Buy technically.
  • BIIB stock price is 192.08 and Biogen, Inc. 200-day simple moving average is 150.33, creating a Buy signal.

BIIB Technical Analysis vs Fundamental Analysis

Buy
52
Biogen, Inc. (BIIB) is a Buy

Is Biogen, Inc. a Buy or a Sell?

  • Biogen, Inc. stock is rated a Buy
    The current Biogen, Inc. [BIIB] share price is $192.08. The Score for BIIB is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.

Biogen, Inc. Stock Info

Market Cap:
28.2B
Price in USD:
192.08
Share Volume:
993.3K

Biogen, Inc. 52-Week Range

52-Week High:
202.41
52-Week Low:
110.04
Buy
52
Biogen, Inc. (BIIB) is a Buy

Biogen, Inc. Share Price Forecast

  • What is the Biogen, Inc. stock price today?
    The Biogen, Inc. stock price is 192.08 USD today.
  • Will BIIB stock go up or go down?
    Biogen, Inc.> share price is forecast to RISE/FALL based on technical indicators
  • Is Biogen, Inc. overvalued?
    According to simple moving average, exponential moving average, oscillators, and other technical indicators, Biogen, Inc. is not overvalued.

Is Biogen, Inc. Stock a Buy?

  • Biogen, Inc. share price is 192.08 while BIIB 8-day exponential moving average is 192.51, which is a Sell signal.
  • The stock price of BIIB is 192.08 while Biogen, Inc. 20-day EMA is 187.33, which makes it a Buy.
  • Biogen, Inc. 50-day exponential moving average is 179.86 while BIIB share price is 192.08, making it a Buy technically.
  • BIIB stock price is 192.08 and Biogen, Inc. 200-day simple moving average is 161.84, creating a Buy signal.

Fundamental Analysis of Biogen, Inc.

Is Biogen, Inc. a good investment?

  • Analysts estimate an earnings increase this quarter of $0.40 per share, a decrease next quarter of $0.66 per share, an increase this year of $0.64 per share, and an increase next year of $0.65 per share.

Technical Analysis of Biogen, Inc.

Should I short Biogen, Inc. stock?

* Biogen, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.